| DCIS | χ2 analysis p-value | Invasive carcinoma no special type | χ2 analysis p-value | ILC | χ2 analysis p-value | |
---|---|---|---|---|---|---|---|
No. of patients | Â | 15 | Â | 122 | Â | 19 | Â |
Tumour size | Median (mm) Range (mm) | 38 7–72 |  | 20 6–90 |  | 26 8–100 |  |
 ≥ 2 cm |  | 10/15 | 0.429 | 65/122 | 0.071 | 14/19 | 0.118 |
T2 intensity | Hypointensity Isointensity Hyperintensity | 0/15 12/15 3/15 | < 0.001 | 55/122 30/122 37/122 | 0.015a | 9/19 5/19 5/19 | 0.833 |
Mass enhancement |  | 2/15 | < 0.001 | 102/122 |  < 0.001 | 12/19 | 0.233 |
Rim enhancement | Â | 0/2 | 0.292 | 39/102 | 0.079 | 2/12 | 0.153 |
Intralesional necrosis | Â | 0/15 | 0.001 | 53/122 | 0.035 | 8/19 | 0.775 |
Perilesional oedema | Â | 6/15 | 0.358 | 67/122 | 0.085 | 7/19 | 0.179 |
Axillary adenopathy | Â | 0/15 | 0.003 | 48/122 | 0.007 | 5/19 | 0.452 |
Intensity-to-time curve | Type I Type II Type III | 1/15 5/15 9/15 | 0.801 | 10/122 31/122 81/122 | 0.877 | 2/19 5/19 12/19 | 0.932 |
ADC value | Very low Low Intermediate | 3/10 6/10 1/10 | 0.055 | 70/111 39/111 2/111 | 0.144 | 7/14 7/14 0/14 | 0.575 |
Extent of disease | Unifocal Multifocal Multicentric | 7/15 0/15 8/15 | 0.018 a | 55/122 39/122 28/122 | 0.02 | 9/19 2/19 8/19 | 0.170 |